Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian, Charles G. Drake, Drew M. Pardoll
Cancer Cell (2015) Vol. 27, Iss. 4, pp. 450-461
Open Access | Times Cited: 3733

Showing 1-25 of 3733 citing articles:

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith, et al.
Science (2017) Vol. 357, Iss. 6349, pp. 409-413
Open Access | Times Cited: 5711
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies, Edward W. Roberts, Kelly Kersten, et al.
Nature Medicine (2018) Vol. 24, Iss. 5, pp. 541-550
Open Access | Times Cited: 4450
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo, et al.
Cell (2017) Vol. 168, Iss. 4, pp. 707-723
Open Access | Times Cited: 4390
Elements of cancer immunity and the cancer–immune set point
Daniel S. Chen, Ira Mellman
Nature (2017) Vol. 541, Iss. 7637, pp. 321-330
Closed Access | Times Cited: 4315
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
Robert L. Ferris, George R. Blumenschein, Jérôme Fayette, et al.
New England Journal of Medicine (2016) Vol. 375, Iss. 19, pp. 1856-1867
Open Access | Times Cited: 4291
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau, et al.
The Lancet (2017) Vol. 389, Iss. 10088, pp. 2492-2502
Open Access | Times Cited: 3855
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Vancheswaran Gopalakrishnan, Christine N. Spencer, Luigi Nezi, et al.
Science (2017) Vol. 359, Iss. 6371, pp. 97-103
Open Access | Times Cited: 3844
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
Florian R. Greten, Sergei I. Grivennikov
Immunity (2019) Vol. 51, Iss. 1, pp. 27-41
Open Access | Times Cited: 2786
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Spencer C. Wei, Colm R. Duffy, James P. Allison
Cancer Discovery (2018) Vol. 8, Iss. 9, pp. 1069-1086
Open Access | Times Cited: 2588
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Suzanne L. Topalian, Janis M. Taube, Robert A. Anders, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 5, pp. 275-287
Open Access | Times Cited: 2396
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
Giampaolo Bianchini, Justin M. Balko, Ingrid A. Mayer, et al.
Nature Reviews Clinical Oncology (2016) Vol. 13, Iss. 11, pp. 674-690
Open Access | Times Cited: 2383
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
Weiping Zou, Jedd D. Wolchok, Lieping Chen
Science Translational Medicine (2016) Vol. 8, Iss. 328
Open Access | Times Cited: 2137
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Jonathan J. Havel, Diego Chowell, Timothy A. Chan
Nature reviews. Cancer (2019) Vol. 19, Iss. 3, pp. 133-150
Open Access | Times Cited: 1956
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
Nisha Nagarsheth, Max S. Wicha, Weiping Zou
Nature reviews. Immunology (2017) Vol. 17, Iss. 9, pp. 559-572
Open Access | Times Cited: 1841
Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing
Chunhong Zheng, Liangtao Zheng, Jae‐Kwang Yoo, et al.
Cell (2017) Vol. 169, Iss. 7, pp. 1342-1356.e16
Open Access | Times Cited: 1824
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Hugo González, Catharina Hagerling, Zena Werb
Genes & Development (2018) Vol. 32, Iss. 19-20, pp. 1267-1284
Open Access | Times Cited: 1755
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli, Pamela L. Strissel, Alexis Desrichard, et al.
Cell (2015) Vol. 162, Iss. 5, pp. 974-986
Open Access | Times Cited: 1696
Single-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Elham Azizi, Ambrose Carr, George Plitas, et al.
Cell (2018) Vol. 174, Iss. 5, pp. 1293-1308.e36
Open Access | Times Cited: 1687
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet, Robert Montal, Daniela Sia, et al.
Nature Reviews Clinical Oncology (2018) Vol. 15, Iss. 10, pp. 599-616
Open Access | Times Cited: 1624
Nanotechnology for Multimodal Synergistic Cancer Therapy
Wenpei Fan, Bryant C. Yung, Peng Huang, et al.
Chemical Reviews (2017) Vol. 117, Iss. 22, pp. 13566-13638
Closed Access | Times Cited: 1595
Targeting macrophages: therapeutic approaches in cancer
Luca Cassetta, Jeffrey W. Pollard
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 12, pp. 887-904
Open Access | Times Cited: 1580
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe, Kristen E. Pauken
Nature reviews. Immunology (2017) Vol. 18, Iss. 3, pp. 153-167
Closed Access | Times Cited: 1569
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane, Mohamed S. Abdel-Hakeem, E. John Wherry
Annual Review of Immunology (2019) Vol. 37, Iss. 1, pp. 457-495
Open Access | Times Cited: 1496
T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
Alexander C. Huang, Michael A. Postow, Robert J. Orlowski, et al.
Nature (2017) Vol. 545, Iss. 7652, pp. 60-65
Open Access | Times Cited: 1479
Every step of the way: integrins in cancer progression and metastasis
Hellyeh Hamidi, Johanna Ivaska
Nature reviews. Cancer (2018) Vol. 18, Iss. 9, pp. 533-548
Open Access | Times Cited: 1216
Page 1 - Next Page

Scroll to top